Using artificial intelligence to improve treatment for multiple brain metastases
An artificial intelligence-driven distributed stereotactic radiosurgery strategy for multiple brain metastases management
['FUNDING_R01'] · UT SOUTHWESTERN MEDICAL CENTER · NIH-10749026
This study is testing a new AI tool to help doctors plan better treatments for patients with multiple brain tumors, aiming to make radiation therapy more effective while keeping side effects low and improving quality of life.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UT SOUTHWESTERN MEDICAL CENTER (nih funded) |
| Locations | 1 site (DALLAS, UNITED STATES) |
| Trial ID | NIH-10749026 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing the treatment of multiple brain metastases (mBMs) using an artificial intelligence-driven approach. It aims to develop a treatment planning system that utilizes AI to optimize stereotactic radiosurgery (SRS), a method that delivers precise radiation to tumors while minimizing damage to surrounding healthy tissue. The study will involve clinical trials to evaluate the effectiveness of this AI system in improving treatment outcomes and preserving patients' quality of life post-treatment. By addressing the challenges of treating multiple brain tumors, this research seeks to provide a safer and more effective treatment option for patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with multiple brain metastases who are seeking advanced treatment options.
Not a fit: Patients with a single brain metastasis or those who are not candidates for stereotactic radiosurgery may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment outcomes and quality of life for patients with multiple brain metastases.
How similar studies have performed: Other research has shown promise in using AI for treatment planning in various medical fields, indicating potential success for this novel approach in managing multiple brain metastases.
Where this research is happening
DALLAS, UNITED STATES
- UT SOUTHWESTERN MEDICAL CENTER — DALLAS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: GU, XUEJUN — UT SOUTHWESTERN MEDICAL CENTER
- Study coordinator: GU, XUEJUN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancers